ImmunityBio, Inc. (IBRX)
7.95
-0.10
(-1.24%)
USD |
NASDAQ |
Aug 31, 16:00
7.88
-0.07
(-0.88%)
After-Hours: 07:32
ImmunityBio Cash and Short Term Investments (Quarterly) : 357.37M for June 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 357.37M |
| March 31, 2026 | 380.88M |
| December 31, 2025 | 242.82M |
| September 30, 2025 | 257.81M |
| June 30, 2025 | 153.66M |
| March 31, 2025 | 61.59M |
| December 31, 2024 | 149.81M |
| September 30, 2024 | 130.37M |
| June 30, 2024 | 217.98M |
| March 31, 2024 | 170.50M |
| December 31, 2023 | 266.46M |
| September 30, 2023 | 189.80M |
| June 30, 2023 | 45.95M |
| March 31, 2023 | 91.27M |
| December 31, 2022 | 107.18M |
| September 30, 2022 | 111.06M |
| June 30, 2022 | 82.94M |
| March 31, 2022 | 192.33M |
| December 31, 2021 | 317.12M |
| September 30, 2021 | 80.37M |
| June 30, 2021 | 103.93M |
| March 31, 2021 | 83.27M |
| December 31, 2020 | 66.21M |
| September 30, 2020 | 89.04M |
| Date | Value |
|---|---|
| June 30, 2020 | 110.62M |
| March 31, 2020 | 40.22M |
| December 31, 2019 | 51.65M |
| September 30, 2019 | 66.06M |
| June 30, 2019 | 84.30M |
| March 31, 2019 | 99.75M |
| December 31, 2018 | 74.15M |
| September 30, 2018 | 84.03M |
| June 30, 2018 | 105.30M |
| March 31, 2018 | 121.79M |
| December 31, 2017 | 128.15M |
| September 30, 2017 | 152.27M |
| June 30, 2017 | 175.50M |
| March 31, 2017 | 190.97M |
| December 31, 2016 | 198.92M |
| September 30, 2016 | 209.26M |
| June 30, 2016 | 213.76M |
| March 31, 2016 | 221.76M |
| December 31, 2015 | 294.22M |
| September 30, 2015 | 358.62M |
| June 30, 2015 | 120.44M |
| March 31, 2015 | 49.85M |
| December 31, 2014 | 59.10M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Moderna, Inc. | 5.138B |
| Sarepta Therapeutics, Inc. | 788.49M |
| Arrowhead Pharmaceuticals, Inc. | 1.602B |
| Oncolytics Biotech, Inc. | 4.115M |
| Sangamo Therapeutics, Inc. | 27.59M |